AnaCardio Publishes AC01 Heart Failure Study in The Lancet
STOCKHOLM, Sweden, June 25, 2026 AnaCardio announced that results from its Phase 1b/2a GOAL-HF1 clinical trial evaluating AC01, a...
HFrEF
Advertisement
BioCardia Gains FDA Support for Heart Failure Therapy
SUNNYVALE, Calif., June 5, 2026 BioCardia, Inc. announced that it has received official meeting minutes from the U.S. Food...
Leica Biosystems and CellCarta Advance AI-Driven Companion Diagnostics Worldwide
MONTREAL, Canada, May 29, 2026 Leica Biosystems, a global leader in anatomic and digital pathology solutions, and CellCarta, a...
Cardiosense Wins FDA De Novo for AI Heart Failure Technology
CHICAGO, Ill., May 29, 2026 Cardiosense has achieved a major regulatory milestone with the U.S. Food and Drug Administration...
Advertisement
